Cypress Capital Group
- SEC CIK
- 0001341748
- Latest filing
- Aug 5, 2026
ADCT holding history
ADC Therapeutics SA in every 13F filed by Cypress Capital Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q2 2023 | 10,000 | $21.5K | <0.1% | +10,000 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q3 2022 | 10,000 | $48.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,000 | $80.0K | <0.1% | +10,000 | New | Holders |